Alto Neuroscience, Inc. (ANRO) vs Replimune Group, Inc. (REPL)
Alto Neuroscience, Inc. and Replimune Group, Inc. are both Biotechnology companies. Replimune Group, Inc. is the larger, with a market value of $1.2B against $1.1B — 1.1× the size. Across the 10 metrics below, Alto Neuroscience, Inc. leads on 9 and Replimune Group, Inc. on 1.
Valuation
Profitability
| Metric | ANRO | REPL | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (49.17%) | (134.29%) | (57.72%) |
| Return on assets | (40.90%) | (82.28%) | (49.22%) |
| Return on invested capital | 0.00% | (1,154.69%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack